NAYA Biosciences, Inc (NAYA) — Cash Flow-to-Debt Ratio
NAYA Biosciences, Inc (NAYA) has a Cash Flow-to-Debt Ratio of -0.02x as of December 2024, meaning its operating cash flow of $-617.38K could theoretically repay 0% of its total liabilities ($33.70 Million) in one year. Explore how much of NAYA Biosciences, Inc's assets are long-term investments to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
NAYA Biosciences, Inc Cash Flow-to-Debt Ratio (2007–2024)
Historical debt coverage capacity for NAYA Biosciences, Inc across 14 annual periods. Also explore total assets of NAYA Biosciences, Inc for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for NAYA Biosciences, Inc (2007–2024)
Year-by-year debt coverage analysis for NAYA Biosciences, Inc. For market capitalisation and broader financial context, see NAYA company net worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.09x | $-2.97 Million | $33.70 Million | ▲ +67.3% |
| 2023 | -0.27x | $-4.76 Million | $17.61 Million | ▲ +80.8% |
| 2022 | -1.41x | $-6.60 Million | $4.69 Million | ▲ +26.3% |
| 2021 | -1.91x | $-6.03 Million | $3.16 Million | ▼ -108.3% |
| 2020 | -0.92x | $-4.78 Million | $5.20 Million | ▼ -468.8% |
| 2019 | 0.25x | $1.37 Million | $5.51 Million | ▲ +233.4% |
| 2018 | -0.19x | $-652.97K | $3.50 Million | ▼ -441.0% |
| 2017 | -0.03x | $-181.27K | $5.26 Million | ▲ +47.8% |
| 2016 | -0.07x | $-323.90K | $4.90 Million | ▼ -88.9% |
| 2015 | -0.03x | $-151.62K | $4.34 Million | ▲ +70.5% |
| 2010 | -0.12x | $-315.99K | $2.66 Million | ▲ +54.9% |
| 2009 | -0.26x | $-926.66K | $3.52 Million | ▲ +75.6% |
| 2008 | -1.08x | $-1.07 Million | $988.12K | ▼ -45.8% |
| 2007 | -0.74x | $-116.04K | $156.70K | — |